Dataset Open Access

The process of HDAC11 Assay Development: linearity and Km calculation

Abbey, Megha; Vedadi, Masoud


Citation Style Language JSON Export

{
  "publisher": "Zenodo", 
  "DOI": "10.5281/zenodo.1270383", 
  "title": "The process of HDAC11 Assay Development: linearity and Km calculation", 
  "issued": {
    "date-parts": [
      [
        2018, 
        6, 
        4
      ]
    ]
  }, 
  "abstract": "<p>With previously optimized conditions, the linearity range for HDAC11 was obtained and the Km for the substrate was calculated.</p>\n\n<p>&nbsp;</p>\n\n<p><strong>Note: </strong>1. In the assay buffer, BSA conc. is 0.5 mg/ml (instead of 0.5%).</p>\n\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. In the 7.5 ul developer solution, 40 uM of TSA (Trichostatin A) is also included.</p>", 
  "author": [
    {
      "family": "Abbey, Megha"
    }, 
    {
      "family": "Vedadi, Masoud"
    }
  ], 
  "note": "The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, S\u00e3o Paulo Research Foundation-FAPESP, Takeda, and Wellcome.", 
  "type": "dataset", 
  "id": "1270383"
}
122
48
views
downloads
All versions This version
Views 122122
Downloads 4848
Data volume 11.4 MB11.4 MB
Unique views 101101
Unique downloads 4545

Share

Cite as